Stocktoria
Surgery Partners, Inc. SGRY
Nasdaq · stock · Services-General Medical & Surgical Hospitals, NEC · website · IPO 2015-10-01 · LEI
Surgery Partners, Inc. financials (annual)
Bars are annual figures from 2015 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.7B | $2.5B | $2.2B | $1.9B | $1.8B | $1.8B | $1.1B | $959.9M |
| Operating income | $389.5M | $348.8M | $328.0M | $345.2M | $302.2M | $183.0M | $235.9M | $77.8M | $196.5M | $144.8M |
| Income tax | $18.0M | $134.6M | -$300,000 | $23.3M | $10.5M | -$20.1M | $9.5M | $26.4M | $7.1M | -$149.0M |
| Net income | -$77.9M | -$168.1M | -$11.9M | -$54.6M | -$70.9M | -$116.1M | -$74.8M | -$205.7M | $9.5M | $1.4M |
| EPS (diluted) | $-0.61 | $-1.33 | $-0.09 | $-0.59 | $-1.12 | $-3.19 | $-2.29 | $-4.96 | $0.20 | $0.04 |
| Operating cash flow | $274.3M | $300.1M | $293.8M | $158.8M | $87.1M | $246.9M | $129.5M | $144.6M | $125.2M | $84.5M |
| Free cash flow | $195.6M | $209.7M | $205.0M | $78.2M | $29.5M | $204.0M | $55.9M | $104.8M | $86.1M | $51.0M |
| Cash & equivalents | $239.9M | $269.5M | $195.9M | $282.9M | $389.9M | $317.9M | $92.7M | $184.3M | $69.7M | $57.9M |
| Inventory | $96.6M | $88.4M | $75.2M | $71.4M | $61.1M | $56.4M | $46.3M | $43.4M | $28.8M | $25.6M |
| Total assets | $8.1B | $7.9B | $6.9B | $6.7B | $6.1B | $5.4B | $5.0B | $4.7B | $2.3B | $2.1B |
| Shareholders' equity | $3.1B | $3.2B | $3.0B | $2.9B | $2.0B | $882.1M | $983.4M | $1.1B | $324.7M | $297.9M |
Growth · year-over-year · Revenue CAGR 14.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +6.2% | +13.5% | +8.0% | +14.1% | +19.6% | +1.6% | +3.4% | +54.7% | +19.3% | +138.0% |
| Net income growth | — | — | — | — | — | — | — | -2276.0% | +561.5% | — |
| EPS growth | — | — | — | — | — | — | — | -2580.0% | +400.0% | — |
| Free cash flow growth | -6.7% | +2.3% | +162.1% | +165.1% | -85.5% | +264.9% | -46.7% | +21.7% | +68.7% | +259.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.